Search for Clinical Trial Results
Mastocytosis - 83 Studies Found
Status | Study |
Completed |
Study Name: Midostaurin in Indolent Systemic Mastocytosis Condition: Indolent Systemic Mastocytosis Date: 2013-08-07 Interventions: Drug: Midostaurin, Midostaurin, twice daily 100 mg orally, continuously for 6 months |
Completed |
Study Name: Stem Cell Transplantation to Treat Systemic Mastocytosis Condition: Mastocytosis Date: 2000-10-17 Interventions: Procedure: Stem cell transplantation |
Completed |
Study Name: Use of Tamoxifen in Systemic Mastocytosis Condition: Systemic Mastocytosis Date: 2007-12-25 |
Completed |
Study Name: Evaluation of Response of Dasatinib to Treat Mastocytosis Condition: Systemic Mastocytosis Date: 2009-09-16 Interventions: Drug: Dasatinib Starting dosage 20mg once daily, that can be escalated up to 100mg once daily. Patient w |
Completed |
Study Name: Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation Condition: Patients With Mastocytosis With Handicap and Bearing Mutations Asp-816-Val (D816V) Date: 2010-12-23 Interventions: Drug: masitinib |
Completed |
Study Name: Treatment of Indolent Systemic Mastocytosis With PA101 Condition:
|
Terminated |
Study Name: Obatoclax for Systemic Mastocytosis Condition:
Date: 2009-06-09 Interventions: Drug: Obatoclax Mesylate 30 mg given by vein over 3 hours on Days 1-3 of each 14-day study cycle. |
Completed |
Study Name: Blood Factors in Mastocytosis and Unexplained Anaphylaxis and Flushing Condition:
Date: 2002-10-22 |
Completed |
Study Name: Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) Condition:
Date: 2007-06-26 Interventions: Drug: Ontak (Denileukin Diftitox) 9 µg/kg by vein Days 1-5 of a 21 day cycle. |
Recruiting |
Study Name: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 Condition: Indolent Systemic Mastocytosis Date: 2016-06-16 Interventions: Drug: AK002 |